Analysis of the use of prostate specific antigen (PSA) in a health area of the Community of Madrid;Análisis de la utilización del antígeno específico prostático (PSA) en un área sanitaria de la Comunidad de Madrid

Actas urologicas españolas

Volumn 25, Issue 10, 2001, Pages 698-703

  Paez Borda A ^a   Lujan Galan M ^a   Llanes Gonzalez L ^a   Romero Cagigal, I ^a   De La Cal Lopez M A ^a   Miravalles Gonzalez E ^a   Berenguer Sanchez A ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; HEALTH; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; SPAIN;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SPAIN; URBAN HEALTH;

EID: 17644429193     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(01)72704-0     Document Type: Article

References (17)

1. S.H. Woolf Screening for prostate cancer with prostate-specific antigen. An examination of the evidence N Engl J Med 333 1995 1.401 1.405
2. H.J. de Koning F.H. Schröder PSA screening for prostate cancer: the current controversy Ann Oncol 9 1998 1.293 1.296
3. E. Martín M. Luján E. Sánchez A. Herrero A. Páez A. Berenguer Final results of a screening campaign for prostate cancer Eur Urol 35 1999 26 31
4. F.H. Schröder R. Kranse J.B.W. Rietbergen R.F. Hoedemaker W.J. Kirkels members of the ERSPC, section Rótterdam. The European Randomized Study of Screening for Prostate Cancer (ERSPC): an update Eur Urol 35 1999 539 543
5. The International Prostate Screening Trial Evaluation Group: rationale for randomised trials of prostate cancer screening Eur J Cancer 35 2 1999 262 271
6. M. Luján A. Páez L. Llanes I. Romero A. Moreno A. Berenguer Data of Spanish contribution to the European Randomized Study of Screening for Prostate Cancer (ERSPC Braz J Urol 26 2000 510 515
7. Bermsterboer PMM: Evaluation of screening programes. Studies on breast cancer and prostate cancer. Tesis Doctoral, 1999
8. L.L. Roos A. Wajda Record linkage strategies. Part I: estimating information and evaluating approaches Meth Inform Med 30 1991 117 123
9. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1.156 1.161
10. M.K. Brawer M.P. Chetner J. Beatie D.M. Buchner R.L. Vessella P.H. Lange Screening for prostate carcinoma with prostate specific antigen J Urol 147 1992 841 845
11. H.B. Carter J.D. Pearson E.J. Metter Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 1992 2.215 2.220
12. B.S. Kramer M.L. Brown P.C. Prorok A.L. Potoksy J.K. Gohagan Prostate cancer screening: what we know and what we need to know Ann Intern Med 119 1993 914 923
13. P.H. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289 294
14. S.J. Jacobsen S.K. Katusic E.J. Bergstralh Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing JAMA 274 1995 1.445 1.449
15. M.C. Coley M.J. Barry C. Fleming J.H. Wasson M.C. Fahs J.E. Oesterling Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: early detection strategies Urology 46 1995 125 141
16. P.S. Bunting J.H. Miyazaki V. Goel Laboratory survey of prostate specific antigen testing in Ontario Clin Biochem 31 1998 47 49
17. C.M. Coley M.J. Barry C. Fleming M.C. Fahs A.G. Mulley Early detection of prostate cancer. Part II: estimating the risks, benefits ans costs Am Coll Phys Ann Intern Med 126 1997 468 479